Liewald F, Dienemann H, Sunder-Plassmann L
Chirurgische Klinik und Poliklinik, Klinikum Grosshadern der Universität München.
Dtsch Med Wochenschr. 1989 Nov 3;114(44):1692-6. doi: 10.1055/s-2008-1066815.
To establish whether bronchoplastic procedures designed to minimize loss of lung tissue are justifiable for the treatment of bronchial carcinoid tumours, data were analysed from 37 patients (17 men, 20 women, average age 51 [22-70] years) who had undergone surgery for typical (n = 30) or atypical (n = 7) bronchial carcinoids. Conventional tumour resections had been performed in 29 cases and bronchoplastic operations in eight. After an average observation period of 54 months one patient who had undergone lobectomy for a bronchial carcinoid had died of recurrent tumour, and one other patient who had been treated by pneumonectomy for an atypical carcinoid had developed distant metastases. All the other patients were free from tumour at that time. This indicates that patients treated by bronchoplastic procedures do not have any higher incidence of recurrences or any lower chance of survival than those treated by lobectomy or pneumonectomy. A bronchoplastic operation should therefore be the treatment of first choice, provided that the adjacent lung tissue has not been destroyed by retention pneumonia and that lymph node dissection does not reveal any involvement.
为确定旨在尽量减少肺组织损失的支气管成形手术对于支气管类癌肿瘤的治疗是否合理，分析了37例接受典型（n = 30）或非典型（n = 7）支气管类癌手术患者（17例男性，20例女性，平均年龄51 [22 - 70]岁）的数据。29例进行了传统肿瘤切除术，8例进行了支气管成形手术。平均观察期54个月后，1例因支气管类癌接受肺叶切除术的患者死于肿瘤复发，1例因非典型类癌接受全肺切除术的患者发生了远处转移。当时所有其他患者均无肿瘤。这表明接受支气管成形手术治疗的患者与接受肺叶切除术或全肺切除术治疗的患者相比，复发率没有更高，生存率也没有更低。因此，只要相邻肺组织未因潴留性肺炎而被破坏且淋巴结清扫未发现任何受累情况，支气管成形手术应作为首选治疗方法。
